C12N2750/00011 - CPC Classification

ssDNA viruses Details

• C12N2750/00021 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 20
• C12N2750/00022 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 29
• C12N2750/00023 » Virus like particles [VLP] 4
• C12N2750/00031 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 2
• C12N2750/00032 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 8
• C12N2750/00033 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 4
• C12N2750/00034 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein 14
• C12N2750/00041 » Use of virus, viral particle or viral elements as a vector 4
• C12N2750/00051 » Methods of production or purification of viral material 9
• C12N2750/00061 » Methods of inactivation or attenuation 0
• C12N2750/00071 » Demonstrated in vivo effect 7
• C12N2750/00088 » For redistribution 0
• C12N2750/10011 » Circoviridae 8
• C12N2750/12011 » Geminiviridae 4
• C12N2750/14011 » Parvoviridae 8

Recent Application in this class: